All In Biotech

Drug Trial Radar · NCT03670810

A Study of Lasmiditan (LY573144) Over Four Migraine Attacks

Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks

Last checked: Nov 20, 2026Latest source record: Jul 29, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,633 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,633

Actual

Start

Jun 24, 2019

Primary completion

Jun 12, 2020

Study completion Jul 8, 2021

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Sep 14, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The reason for this study is to see how effective and safe the study drug known as lasmiditan is in the acute treatment of 4 migraine attacks with or without aura.

Conditions

  • Migraine

Interventions

  • LasmiditanDrug

    Administered orally.

  • PlaceboDrug

    Administered orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants That Are Pain Free 2 Hours Postdose During the First AttackTime frame: 2 Hours Postdose
  2. Percentage of Participants That Are Pain Free at 2 Hours Postdose in at Least 2 Out of 3 AttacksTime frame: 2 Hours Postdose

Locations

141 sites in 17 countries. Site status is shown where the registry gives one.

  • Rehabilitation & Neurological Services LLC

    Huntsville, Alabama

  • Barrow Neurological Institute

    Phoenix, Arizona

  • UCSD Altman Clinical & Translational Research Institute (ACTRI)

    La Jolla, California

  • Colorado Neurological Institute

    Englewood, Colorado

  • Georgetown University Hospital

    Washington D.C., District of Columbia

  • George Washington University Medical Center

    Washington D.C., District of Columbia

  • Diamond Headache Clinic

    Chicago, Illinois

  • Ochsner Medical Center - North Shore

    Covington, Louisiana

  • StudyMetrix Research, LLC

    City of Saint Peters, Missouri

  • Nevada Headache Institute

    Las Vegas, Nevada

  • Dent Neurological Institute

    Amherst, New York

  • Island Neuro Associates,PC

    Plainview, New York

  • Montefiore Headache Center

    The Bronx, New York

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Christian-Doppler-Klinik

    Salzburg, Austria

  • AKH

    Vienna, Austria

  • Universitätsklinik Innsbruck

    Innsbruck, Tyrol, Austria

  • KH der Barmherzigen Schwestern Linz BetriebsGesmbH

    Linz, Upper Austria, Austria

  • Algemeen Ziekenhuis St Jan Brugge

    Bruges, Belgium

  • Universitair Ziekenhuis Brussel

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • CHC MontLégia

    Liège, Belgium

  • Valdor - ISOSL CCV - Clinique des céphalées du Valdor - Neurology

    Liège, Belgium

  • Jessa Ziekenhuis

    Hasselt, Limburg, Belgium

  • Baotou Central Hospital

    Baotou, China

  • Peking Union Medical College Hospital

    Beijing, China

  • Chinese PLA General Hospital

    Beijing, China

  • The First Affiliated Hospital of Harbin Medical University

    Harbin, China

  • Tianjin Medical University General Hospital

    Tianjin, China

  • Beijing Tiantan Hospital Affiliated to Capital Medical Univ

    Beijing, Beijing Municipality, China

  • Xuanwu Hospital-Capital Medical University

    Beijing, Beijing Municipality, China

  • The First Affiliated Hospital Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China

  • The University of Hong Kong-Shenzhen Hospital

    Shenzhen, Guangdong, China

  • Hebei General Hospital

    Shijiazhuang, Hebei, China

  • First hospital affiliated to Zhengzhou University

    Zhengzhou, Henan, China

  • Wuhan Union (Xiehe) Hospital

    Wuhan, Hubei, China

  • Xiangya Hospital, Central South University

    Changsha, Hunan, China

  • The First Affliated Hospital of Suzhou University

    Suzhou, Jiangsu, China

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, China

Showing 40 of 141 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.